CLINICAL_TRIALS
trial_result
· 2018-03-23
Clinical Trial Update: The Effects of Intravitreal Ozurdex Implant in DME [Phase 4]
Summary
Phase 4 clinical trial update assessing the effects of the intravitreal dexamethasone implant (Ozurdex) in diabetic macular edema.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nune Eye Hospital, Seoul, Korea | Conditions: Diabetic Macular Edema | Phase 4 | Status: UNKNOWN